Hubei Huarong Holding Co.,Ltd.
public_traded
Hubei Huarong Holding Co.,Ltd. is publicly traded on SHH under ticker 600421.SS.
Hubei Huarong Holding Co.,Ltd. produces and distributes pharmaceutical products in China. The company's principal pharmaceutical products include Gucining Capsules and Huoxue Tongmai Capsules. It also develops biological products, pharmaceuticals, environment-protection, and agricultural products, as well as related technologies. The company was formerly known as Hubei Yangfan Holding Co., Ltd. and changed its name to Hubei Huarong Holding Co.,Ltd. in November 2020. Hubei Huarong Holding Co.,Ltd. was founded in 1997 and is headquartered in Wuhan, China.